<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-23T23:35:30+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>姜宝红点评 | Nature：心血管疾病诊断和治疗新靶点——ALDH4A1</title>
    <updated>2020-12-23T20:59:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/Ud_9EhwLp7vbZxuveZmNCQ</id>
    <link href="https://mp.weixin.qq.com/s/Ud_9EhwLp7vbZxuveZmNCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗癌靶点XPO1「图鉴」</title>
    <updated>2020-12-22T20:58:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/1isEKx3qcPjL1inedk-HOA</id>
    <link href="https://mp.weixin.qq.com/s/1isEKx3qcPjL1inedk-HOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature：首个Tau抗体临床试验失败，阿尔茨海默症Tau药物还有哪些希望？</title>
    <updated>2020-12-21T20:58:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/lzoCUobFpgR1HEd6JBEu8g</id>
    <link href="https://mp.weixin.qq.com/s/lzoCUobFpgR1HEd6JBEu8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺华、默沙东之后，GSK又下8.15亿美元大单！这家癌症免疫疗法公司有何重磅产品？</title>
    <updated>2020-12-20T20:59:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/mUQuWNw2OmhWzT0SBeVGoQ</id>
    <link href="https://mp.weixin.qq.com/s/mUQuWNw2OmhWzT0SBeVGoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>变构调节剂领域大放异彩！Biogen和罗氏大额合作后，诺华7.7亿美元收购Cadent</title>
    <updated>2020-12-19T21:00:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/gqbkfG1x1tlItmjMPHSpgA</id>
    <link href="https://mp.weixin.qq.com/s/gqbkfG1x1tlItmjMPHSpgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基因疗法狂欢周！礼来宣布超10亿美元收购Prevail，4家公司累计融资超2.9亿美元</title>
    <updated>2020-12-18T21:06:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/2d3-PtsPsQZUEu04rJ0jCA</id>
    <link href="https://mp.weixin.qq.com/s/2d3-PtsPsQZUEu04rJ0jCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向线粒体抗癌获突破！Nature：POLRMT变构抑制剂有效抗肿瘤，对健康细胞无显著影响</title>
    <updated>2020-12-17T21:00:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/sFWy6Wesj22Cicpc4HbZcA</id>
    <link href="https://mp.weixin.qq.com/s/sFWy6Wesj22Cicpc4HbZcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿尔茨海默症新靶点——Sgk1</title>
    <updated>2020-12-16T21:00:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/GFcoKp-hAQx2dAIwu6nEiQ</id>
    <link href="https://mp.weixin.qq.com/s/GFcoKp-hAQx2dAIwu6nEiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PARP抑制剂“新搭档”——CSF-1R抑制剂</title>
    <updated>2020-12-15T21:02:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/xupWSRJUVul8kp-TaIPFOg</id>
    <link href="https://mp.weixin.qq.com/s/xupWSRJUVul8kp-TaIPFOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature封面：首张癌症转移图谱出炉，涉及21个癌种500株人癌细胞系</title>
    <updated>2020-12-14T21:00:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/wHy6LQfN8PLyCReoSDmvqw</id>
    <link href="https://mp.weixin.qq.com/s/wHy6LQfN8PLyCReoSDmvqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>